NEUROTRANSMITTER

Neurotransmitter

  The pages of this web site article contain an in depth discussion of a new and highly effective neurotransmitter approach to treating medical patients in clinics without drugs or drug side effects. While on the surface this approach may appear similar to treatment attempted by others in the past, it is differentiated from other approaches by the high degree of effectiveness achieved and the unique way the individual components are used. This approach was developed by medical doctors caring for medical patients in their clinics while data basing treatment results. If you need assistance in finding a care giver using the NeuroResearch Clinics no-drug approach in treatment, we can help.

  The research of NeuroResearch Clinics is guided by the largest privately held neurotransmitter data base in the world.  The neurotransmitter data base documents approximately 1.5 million patient-days of treatment from over 650 clinics.

  The research findings of NeuroResearch Clinics have not been ignored. The University of Minnesota Medical School is writing a series of papers on the neurotransmitter testing research of NeuroResearch Clinics. The first University of Minnesota Medical School neurotransmitter testing paper has been accepted for publication in "The Journal of NeuroPsychiatry". It will be published in March of 2009. Ingrid Kohlstadt, MD of Johns Hopkins in her new medical text book released February 7, 2009 included a chapter on depression written by Marty L. Hinz, MD  President Clinical Research NeuroResearch Clinics outlining in depth the proper use of amino acids and neurotransmitter tests in treatment of depression.

  Working with nutrients and neurotransmitter tests are not intuitive. Few things anticipated in neurotransmitter studies actually happened. Without the neurotransmitter statistical data base analysis optimal treatment would have never been defined.

  Its no secret, NeuroResearch Clinics uses the nutrients 5-HTP, tyrosine, levodopa, and cysteine with neurotransmitter tests as indicted to treat disease. Proper use these simple ingredients is not simple. Occasionally a patient will say, "Why should I take that, I buy it in a health food store?" People off the street buying neurotransmitter nutrients in a health food store is like going to an art store and buying oil paints then going home and expecting to paint like a master artist with no previous painting experience. This is sophisticated neurotransmitter medical treatment. Nutrients have tremendous neurotransmitter treatment potential due to the chemical properties. This neurotransmitter is only fully realized by the trained professional.

  The focus of neurotransmitter research is:

• Serotonin

• Dopamine

• Norepinephrine

• Epinephrine

  Function, regulation, and neurotransmitter control is far reaching being involved directly or indirectly with every function of the body. NeuroResearch Clinics is focused on treatment of over 80 neurotransmitter diseases.

  Nothing is intuitive! It was thought when 5-HTP was taken the urinary neurotransmitter serotonin increased. NeuroResearch Clinics has been teaching, "There is no correlation between 5-HTP dosing and urinary serotonin levels" therefore baseline neurotransmitter tests prior to treatment has no value, yet there are labs promoting its use. In 2008 the University of Minnesota Medical School in 2008 settled the neurotransmitter baseline testing controversy in writing on the neurotransmitter research of NeuroResearch Clinics, "Curiously, 5-HTP did not exhibit a clear influence on urinary serotonin excretion when 5-HTP doses were compared to urinary serotonin excretion".

  Many of the neurotransmitter findings and treatment outcomes are discussed on this web site. Neurotransmitter treatment with nutrients are not straight forward and require training. Since the year 2000 NeuroResearch Clinics has trained hundreds of doctors in two day American Medical Association certified category 1 neurotransmitter continuing medical education courses.

The NeuroResearch Clinics Peer Reviewed research

  The research findings of NeuroResearch Clinics have not been ignored. The University of Minnesota Medical School is writing a series of papers on the neurotransmitter testing research of NeuroResearch Clinics. The first University of Minnesota Medical School neurotransmitter testing paper has been accepted for publication in "The Journal of NeuroPsychiatry". It will be published in March of 2009. Ingrid Kohlstadt, MD of Johns Hopkins in her new medical text book released February 7, 2009 included a chapter on depression written by Marty L. Hinz, MD  President Clinical Research NeuroResearch Clinics outlining in depth the proper use of amino acids and neurotransmitter testing in treatment of depression.

neurotransmitter